OBJECTIVE: To evaluate the therapeutic efficacy of a novel modular polymer platform in the treatment of head and neck squamous cell carcinoma (HNSCC). DESIGN: In vivo study. SETTING: Academic research laboratory. Subjects and METHODS: C3H/HeJ mice and SCID/beige mice were randomized to receive implantation of no polymer, plain polymer, plain polymer with local cisplatin injection, or cisplatin polymer. The 2 groups of mice implanted with cisplatin polymer or no polymer were further randomized to receive 4 Gy of external beam radiation for 4 days or no radiation. Tumor size was measured until the mice were humanely killed. At necropsy, the tumors were excised and weighed. RESULTS: There was a significant reduction in tumor growth using this novel polymer platform. The cisplatin-secreting polymer effectively reduced human head and neck tumor growth in SCID mice by 17-fold and SCC VII/SF tumors in C3H/HeJ mice by more than 16-fold compared with the control, plain polymer, and plain polymer + intratumoral cisplatin injection groups (P = .01 for both). We also observed a statistically significant lower tumor weight in mice treated with cisplatin polymer and concomitant radiation compared with the radiation alone and control groups. CONCLUSIONS: We demonstrate the efficacy of a novel polymer platform in delivering cisplatin to a partially resected SCC in a murine model. This polymer may represent a new therapeutic modality for patients with HNSCC. Once this polymer platform is optimized, we will plan for validation in the context of a prospective trial in patients with unresectable advanced or recurrent HNSCC.
OBJECTIVE: To evaluate the therapeutic efficacy of a novel modular polymer platform in the treatment of head and neck squamous cell carcinoma (HNSCC). DESIGN: In vivo study. SETTING: Academic research laboratory. Subjects and METHODS: C3H/HeJmice and SCID/beige mice were randomized to receive implantation of no polymer, plain polymer, plain polymer with local cisplatin injection, or cisplatin polymer. The 2 groups of mice implanted with cisplatin polymer or no polymer were further randomized to receive 4 Gy of external beam radiation for 4 days or no radiation. Tumor size was measured until the mice were humanely killed. At necropsy, the tumors were excised and weighed. RESULTS: There was a significant reduction in tumor growth using this novel polymer platform. The cisplatin-secreting polymer effectively reduced human head and neck tumor growth in SCIDmice by 17-fold and SCC VII/SF tumors in C3H/HeJmice by more than 16-fold compared with the control, plain polymer, and plain polymer + intratumoral cisplatin injection groups (P = .01 for both). We also observed a statistically significant lower tumor weight in mice treated with cisplatin polymer and concomitant radiation compared with the radiation alone and control groups. CONCLUSIONS: We demonstrate the efficacy of a novel polymer platform in delivering cisplatin to a partially resected SCC in a murine model. This polymer may represent a new therapeutic modality for patients with HNSCC. Once this polymer platform is optimized, we will plan for validation in the context of a prospective trial in patients with unresectable advanced or recurrent HNSCC.
Authors: G Colella; R Cannavale; A Vicidomini; G Rinaldi; D Compilato; G Campisi Journal: Int J Immunopathol Pharmacol Date: 2010 Jan-Mar Impact factor: 3.219
Authors: Douglas A Ross; Jagdeep S Hundal; Yung H Son; Stephan Ariyan; Joseph Shin; Roger Lowlicht; Clarence T Sasaki Journal: Laryngoscope Date: 2004-07 Impact factor: 3.325
Authors: Brittany J Poelaert; Svetlana Romanova; Shelby M Knoche; Madeline T Olson; Bailee H Sliker; Kaitlin Smits; Brittney L Dickey; Alexandra E J Moffitt-Holida; Benjamin T Goetz; Nuzhat Khan; Lynette Smith; Hamid Band; Aaron M Mohs; Donald W Coulter; Tatiana K Bronich; Joyce C Solheim Journal: J Control Release Date: 2020-07-22 Impact factor: 9.776
Authors: Manijeh Goldberg; Aaron Manzi; Peter Conway; Stefanie Cantin; Vasudha Mishra; Alka Singh; Alexander T Pearson; Eric R Goldberg; Sam Goldberger; Benjamin Flaum; Rifat Hasina; Nyall R London; Gary L Gallia; Chetan Bettegowda; Sonya E O'Neill; Erkin Aydin; Alex Zhavoronkov; Anxo Vidal; Atenea Soto; Maria Jose Alonso; Ari J Rosenberg; Mark W Lingen; Anil D'Cruz; Nishant Agrawal; Evgeny Izumchenko Journal: Nat Commun Date: 2022-08-17 Impact factor: 17.694